tiprankstipranks
Medtronic (MDT)
NYSE:MDT

Medtronic (MDT) Income Statement

5,225 Followers

Medtronic Income Statement

Last quarter (Q3 2024), Medtronic's total revenue was $8.09B, an increase of 4.68% from the same quarter last year. In Q3, Medtronic's net income was $1.32B. See Medtronic’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Apr 23Apr 22Apr 21Apr 20Apr 19
Total Revenue
$ 32.32B$ 31.23B$ 31.69B$ 30.12B$ 28.91B$ 30.56B
Cost of Revenue
$ 11.15B$ 10.72B$ 10.14B$ 10.48B$ 9.42B$ 9.15B
Gross Profit
$ 21.17B$ 20.51B$ 21.54B$ 19.63B$ 19.49B$ 21.40B
Operating Expense
$ 14.60B$ 14.30B$ 15.54B$ 14.74B$ 14.27B$ 14.77B
Operating Income
$ 6.24B$ 5.49B$ 6.00B$ 4.89B$ 5.22B$ 6.63B
Net Non Operating Interest Income Expense
$ -703.00M$ -636.00M$ -553.00M$ -925.00M$ -1.09B$ -1.44B
Other Income Expense
$ -581.00M$ -515.00M$ -318.00M$ -75.00M$ -75.00M$ 9.00M
Pretax Income
$ 6.15B$ 5.36B$ 5.67B$ 3.90B$ 4.05B$ 5.20B
Tax Provision
$ 1.30B$ 1.58B$ 456.00M$ 265.00M$ -751.00M$ 547.00M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 5.00B$ 4.51B$ 5.19B$ 3.61B$ 4.79B$ 4.63B
Basic EPS
$ 3.15$ 2.83$ 3.75$ 2.68$ 3.57$ 3.44
Diluted EPS
$ 3.14$ 2.82$ 3.73$ 2.66$ 3.54$ 3.41
Basic Average Shares
$ 5.32B$ 1.33B$ 1.34B$ 1.34B$ 1.34B$ 1.35B
Diluted Average Shares
$ 5.33B$ 1.33B$ 1.35B$ 1.35B$ 1.35B$ 1.36B
Dividend Per Share
$ 3.43$ 2.72$ 2.52$ 2.32$ 2.16$ 2.00
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
---$ 4.44$ 4.59$ 5.22
Rent Expense Supplemental
------
Total Expenses
$ 25.75B$ 25.02B$ 25.68B$ 25.22B$ 23.69B$ 23.93B
Net Income From Continuing And Discontinued Operation
$ 4.81B$ 3.76B$ 5.19B$ 3.61B$ 4.79B$ 4.63B
Normalized Income
$ 5.65B$ 3.96B$ 4.27B$ 3.99B$ 5.10B$ 4.96B
Interest Expense
---$ 925.00M$ 1.09B$ 1.44B
EBIT
$ 6.85B$ 6.00B$ 6.22B$ 4.82B$ 5.15B$ 6.64B
EBITDA
$ 5.05B$ 8.70B$ 8.93B$ 7.52B$ 7.81B$ 9.30B
Currency in USD

Medtronic Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis